09/20/2023

ASH Sends Letters to Congress on Ongoing Drug Shortages in the United States

ASH continues to raise awareness about the impact of the ongoing drug shortages in the United States, and encourage Congressional action. To address this issue, the House Energy and Commerce Subcommittee on Health held a congressional hearing earlier today to discuss legislative proposals to prevent and respond to generic drug shortages.  The Society recently sent the following two letters to Congressional leaders as different policy solutions are considered:

• In late August, ASH sent a letter to Representative Cathy McMorris Rodgers (R-WA-5), Chair of the House Energy & Commerce Committee, recommending changes to draft legislation entitled Stop Drug Shortages Act. 
• On September 13, ASH sent a letter to Congressional leaders about the need for timely and comprehensive action on drug shortages, including those that impact hematology care.

Join us in this advocacy to ensure your elected officials hear from you about this critical topic and the impact it is having on your patients, by visiting the ASH Advocacy Center.